CARTER TODD ALFRED (Chief Scientific Officer) sold 4.1% of their position (3.31K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $14.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/24/2025ACC: 0001104659-25-016522
Officer· Chief Scientific Officer
Since Feb 2026
+134.69K
Net shares
Net buyer
$14.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
138K acquired · 3.31K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−3.31K
Price / share
$4.26
Trade value
$14.08K
% of position
4.1%
2/20/2025
81.02K→77.72K
Common Stock
Direct
Shares
+46K
Price / share
—
Trade value
—
% of position
59.2%
2/21/2025
77.72K→123.72K
Total
Net shares
+42.70K
Net value
-$14.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2025 | S · Sale | −3.31K | $4.26 | $14.08K | 4.1% | 81.02K | 77.72K |
| Common Stock Direct | 2/21/2025 | A · Award | +46K | — | — | 59.2% | 77.72K | 123.72K |
| Total | +42.70K | -$14.08K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
92K shares
Shares
+92K
Strike price
4.22
Held after
92K
Exercisable
—
2/21/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock92K shares | 2/21/2025 | A · Award | +92K | 4.22 | — | 92K |